GPAT vs MRNA: Correlation
Measured on weekly returns over the past three years, GP-Act III Acquisition Corp. - Class A (GPAT) and Moderna (MRNA) carry a correlation of -0.32, a negative link.
Data as of 2026-08-27 · refreshed every trading day · weekly returns · methodology
How correlated are GPAT and MRNA?
Over the past 3 years, GPAT and MRNA moved with a correlation of -0.32, which is negative, meaning they tend to move in opposite directions. Recent behaviour matches the longer record: -0.42 over 1 year against -0.32 over 3. Over 5 years the correlation is n/a, and the annualized covariance of weekly returns is -113.2 %².
Out of 22 assets tracked against GPAT, MRNA lands near the bottom at #20. Their recent paths diverged sharply: over the last 12 months MRNA outperformed by 465.4 percentage points (+3.4% for GPAT against +468.8% for MRNA). One caveat on sizing: MRNA is 31.5 times as volatile as the other leg, so an equal-dollar split is far from equal-risk.
How is this computed?
Pearson correlation on weekly returns: ρ(A,B) = cov(rA, rB) / (σA · σB), over windows of 52, 156 and 260 weeks. Covariance is annualized (×52) and expressed in %². Full definitions on the methodology page.
GPAT vs MRNA: side by side
| GPAT (GP-Act III Acquisition Corp. - Class A) | MRNA (Moderna) | |
|---|---|---|
| 1-year return | +3.4% | +468.8% |
| 5-year return | n/a | -61.5% |
| Volatility (ann.) | 3.2% | 100.7% |
| Beta vs S&P 500 | 0.05 | 0.98 |
| Max drawdown (3Y) | -2.1% | -86.6% |
| Market cap | $0.2B | $57.0B |
| P/E (trailing) | 44.6 | – |
| Dividend yield | 0.00% | 0.00% |
| Sector / category | US Listed | Health Care |
Year-by-year returns
| Year | GPAT | MRNA |
|---|---|---|
| 2022 | – | -29.3% |
| 2023 | – | -44.6% |
| 2024 | – | -58.2% |
| 2025 | +5.4% | -29.1% |
| 2026 | +2.2% | +384.1% |
Calendar-year price returns; the current year is year-to-date as of the data date above.
Are GPAT and MRNA good diversifiers for each other?
Yes: at -0.32, the two have gone their own ways historically, which is what genuine diversification looks like.
FAQ
What is the correlation between GPAT and MRNA?
As of 2026-08-27, the correlation of weekly returns between GPAT and MRNA is -0.32 over 3 years, -0.42 over 1 year and n/a over 5 years.
Is MRNA a good diversifier for GPAT?
Yes: at -0.32, the two have gone their own ways historically, which is what genuine diversification looks like.
What does a correlation of -0.32 mean?
A reading of -0.32 sits on a scale from −1 (opposite moves) through 0 (unrelated) to +1 (identical moves). Correlation captures direction, not magnitude or performance.
Use this data
$ curl https://www.pairbook.io/api/v1/pairs/gpat-vs-mrna.json
Markdown for the live badge, attribution link included:
[](https://www.pairbook.io/pair/gpat-vs-mrna/)
No key needed, free to use. Full endpoint list in the API documentation.
Related comparisons
Hubs: GPAT correlations · MRNA correlations